The Cell Biology of the Trichosporon-Host Interaction

Cláudio Duarte-Oliveira1,2, Fernando Rodrigues1,2, Samuel M Gonçalves1,2

  • 1Life and Health Sciences Research Institute (ICVS), School of Medicine, University of MinhoBraga, Portugal.

Insights

Fungi in the *Trichosporon* genus are emerging causes of human fungal infections, especially in immunocompromised individuals. This review explores their virulence factors and host immune interactions, suggesting new diagnostic and therapeutic strategies.

Area of Science:

  • Medical Mycology
  • Immunology
  • Microbial Pathogenesis

Background:

  • Fungi of the genus *Trichosporon* are increasingly identified as pathogens causing superficial and invasive infections in humans.
  • While often commensals, *Trichosporon* species pose a growing threat to immunocompromised hosts, including hematological and transplant patients.

Purpose of the Study:

  • To review current knowledge on the virulence attributes of *Trichosporon* species, with a focus on *T. asahii*.
  • To elucidate the interaction between *Trichosporon* virulence factors and the host immune system.
  • To propose novel perspectives for fungal diagnostics and therapeutics.

Main Methods:

  • Literature review and synthesis of existing research on *Trichosporon* virulence.
  • Analysis of host-pathogen interactions, focusing on immune evasion mechanisms.
  • Exploration of current and potential diagnostic and therapeutic approaches.

Main Results:

  • *Trichosporon* spp. adapt to the host microenvironment, initiating pathogenic programs through unknown virulence factors.
  • The intricate biology of the fungal cell wall and its role in virulence require further investigation.
  • Understanding these interactions is crucial for developing effective treatments.

Conclusions:

  • *Trichosporon* infections represent a significant clinical challenge, particularly in vulnerable populations.
  • Further research into *Trichosporon* virulence mechanisms and host immune responses is essential.
  • Novel diagnostic and therapeutic strategies are needed to combat these emerging fungal pathogens.